Please Wait
Applying Filters...
menu
    • menu
    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    Kikkoman Biochemifa Company advances global health and safety through precision-driven innovation in biotech and food testing.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-10-20

    Virtual Booth

    An Enquiry

    Menu

    Burixafor

    DEVELOPMENTS

    INTERMEDIATES

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Exicure Highlights Achievements, Strategic Priorities
    Exicure Highlights Achievements, Strategic Priorities

    06 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/06/3161574/33289/en/Exicure-Highlights-Recent-Achievements-and-Near-term-Strategic-Priorities.html

    GLOBENEWSWIRE
    06 Oct 2025
    Share Share
    Exicure Completes Patient Enrollment in Phase 2 Study of GPC-100
    Exicure Completes Patient Enrollment in Phase 2 Study of GPC-100

    05 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250505513656/en/Exicure-Completes-Patient-Enrollment-in-Phase-2-Study-of-GPC-100-for-Stem-Cell-Mobilization-in-Multiple-Myeloma-Patients-Undergoing-Autologous-Transplant

    BUSINESSWIRE
    05 May 2025
    Share Share
    PharmaVentures advises GPCR Therapeutics on their acquisition of Burixafor
    PharmaVentures advises GPCR Therapeutics on their acquisition of Burixafor

    24 Nov 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/pharmaventures-advises-gpcr-therapeutics-on-their-acquisition-of-burixafor-301179049.html#:~:text=PharmaVentures%20advises%20GPCR%20Therapeutics%20on%20their%20acquisition%20of%20Burixafor,-News%20provided%20by&text=(GPCR)%20providing%20due%20diligence%20for,of%20Burixafor%20for%20worldwide%20markets.

    PRNEWSWIRE
    24 Nov 2020
    Share Share